• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Viruses . Effect of Inactivation Methods on SARS-CoV-2 Virion Protein and Structure

tetano

Editor, Senior Moderator
Viruses


. 2021 Mar 26;13(4):562.
doi: 10.3390/v13040562.
Effect of Inactivation Methods on SARS-CoV-2 Virion Protein and Structure


Emma K Loveday[SUP] 1 [/SUP], Kyle S Hain[SUP] 2 [/SUP], Irina Kochetkova[SUP] 2 [/SUP], Jodi F Hedges[SUP] 2 [/SUP], Amanda Robison[SUP] 2 [/SUP], Deann T Snyder[SUP] 2 [/SUP], Susan K Brumfield[SUP] 3 [/SUP], Mark J Young[SUP] 3 [/SUP], Mark A Jutila[SUP] 2 [/SUP], Connie B Chang[SUP] 1 [/SUP], Matthew P Taylor[SUP] 2 [/SUP]



Affiliations

Abstract

The risk posed by Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2) dictates that live-virus research is conducted in a biosafety level 3 (BSL3) facility. Working with SARS-CoV-2 at lower biosafety levels can expedite research yet requires the virus to be fully inactivated. In this study, we validated and compared two protocols for inactivating SARS-CoV-2: heat treatment and ultraviolet irradiation. The two methods were optimized to render the virus completely incapable of infection while limiting the destructive effects of inactivation. We observed that 15 min of incubation at 65 ?C completely inactivates high titer viral stocks. Complete inactivation was also achieved with minimal amounts of UV power (70,000 ?J/cm[SUP]2[/SUP]), which is 100-fold less power than comparable studies. Once validated, the two methods were then compared for viral RNA quantification, virion purification, and antibody detection assays. We observed that UV irradiation resulted in a 2-log reduction of detectable genomes compared to heat inactivation. Protein yield following virion enrichment was equivalent for all inactivation conditions, but the quality of resulting viral proteins and virions were differentially impacted depending on inactivation method and time. Here, we outline the strengths and weaknesses of each method so that investigators might choose the one which best meets their research goals.

Keywords: ELISA; SARS-CoV-2; UV inactivation; electron microscopy; heat inactivation; western blot.
 
Back
Top Bottom